Literature DB >> 24900060

Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer?

Dae-Weung Kim1, Woo Hyoung Kim1, Chang Guhn Kim1.   

Abstract

PURPOSE: Dual-time-point (DTP) FDG PET/CT has been shown to be useful for lymph node (LN) staging in patients with non-small-cell lung cancer (NSCLC). The aim of this study was to evaluate the LN staging ability of DTP FDG PET/CT in the predominant area of pulmonary tuberculosis.
METHODS: Sixty-nine NSCLC patients underwent DTP PET/CT. Regions of interest were placed on each LN of each station, and the maximum SUVs were measured. Three variables were obtained: (1) the SUV on the early scan (SUVearly), (2) the SUV on the delayed scan (SUVdelayed), and (3) the retention index of the SUV (RI). Each patient had one final LN stage and three other LN stages according to the cutoff values of SUVearly, SUVdelayed, and RI.
RESULTS: In the LN-based analysis, the area under the ROC curve of SUVdelayed (0.884) was significantly larger (P < 0.01) than those of SUVearly (0.868) and RI (0.717). Among the three variables, SUVdelayed was more accurate (P < 0.01) for detecting the mediastinal LN metastasis than SUVearly and RI. In the patient-based analysis, SUVdelayed had correctly determined LN stages in 55 of 69 patients (sensitivity, specificity, and accuracy = 88.7 %, 50.0 %, and 79.7 %), whereas SUVearly and RI correctly determined LN stages in 53 and 52 patients, respectively.
CONCLUSIONS: In this study, comparing the diagnostic efficacy of SUVearly, SUVdelayed, and RI for LN staging in patients with NSCLC, SUVdelayed was the most accurate variable for LN staging. DTP PET/CT could provide improved diagnostic accuracy for the LN staging of NSCLC.

Entities:  

Keywords:  Dual-time-point imaging; Fluorodeoxyglucose; Lymph node staging; Non-small-cell lung cancer; Positron emission tomography

Year:  2012        PMID: 24900060      PMCID: PMC4043038          DOI: 10.1007/s13139-012-0141-0

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

1.  Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.

Authors:  Dae-Weung Kim; Chang Guhn Kim
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

2.  Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.

Authors:  Takami Kasai; Ken Motoori; Takuro Horikoshi; Katsuhiro Uchiyama; Kazuhiro Yasufuku; Yuichi Takiguchi; Fumiaki Takahashi; Yoshio Kuniyasu; Hisao Ito
Journal:  Eur J Radiol       Date:  2009-05-15       Impact factor: 3.528

3.  Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.

Authors:  Kazuya Takamochi; Junji Yoshida; Koji Murakami; Seiji Niho; Genichiro Ishii; Mitsuyo Nishimura; Yutaka Nishiwaki; Kazuya Suzuki; Kanji Nagai
Journal:  Lung Cancer       Date:  2005-02       Impact factor: 5.705

4.  Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.

Authors:  Kazuyoshi Suga; Yasuhiko Kawakami; Atsuto Hiyama; Kazurou Sugi; Kazutomo Okabe; Tsuneo Matsumoto; Kazuhiro Ueda; Nobuyuki Tanaka; Naofumi Matsunaga
Journal:  Ann Nucl Med       Date:  2009-05-15       Impact factor: 2.668

5.  18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

Authors:  Ruoh-Fang Yen; Ke-Cheng Chen; Jang-Ming Lee; Yeun-Chung Chang; Jane Wang; Mei-Fang Cheng; Yen-Wen Wu; Yung-Chie Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-19       Impact factor: 9.236

6.  Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.

Authors:  Jun Konishi; Koichi Yamazaki; Eriko Tsukamoto; Nagara Tamaki; Yuya Onodera; Toshiyuki Otake; Toshiaki Morikawa; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Respiration       Date:  2003 Sep-Oct       Impact factor: 3.580

7.  Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.

Authors:  R Kubota; K Kubota; S Yamada; M Tada; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

8.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

9.  Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

Authors:  Alexander Matthies; Marc Hickeson; Andrew Cuchiara; Abass Alavi
Journal:  J Nucl Med       Date:  2002-07       Impact factor: 10.057

10.  Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Authors:  Daisuke Uesaka; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Masato Sasaki; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

View more
  9 in total

Review 1.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

Authors:  Muhammad Kashif Rahim; Sung Eun Kim; Hyeongryul So; Hyung Jun Kim; Gi Jeong Cheon; Eun Seong Lee; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-01-22

2.  Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.

Authors:  Jai Hyuen Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-06

3.  Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.

Authors:  Ah Young Lee; Su Jung Choi; Kyung Pyo Jung; Ji Sun Park; Seok Mo Lee; Sang Kyun Bae
Journal:  Nucl Med Mol Imaging       Date:  2013-11-06

4.  Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?

Authors:  Benedikt M Schaarschmidt; Johannes Grueneisen; Martin Metzenmacher; Benedikt Gomez; Thomas Gauler; Christian Roesel; Philipp Heusch; Verena Ruhlmann; Lale Umutlu; Gerald Antoch; Christian Buchbender
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

5.  Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.

Authors:  Julian M M Rogasch; Ingo G Steffen; Sandra Riedel; Ivayla Apostolova; Heinz Wertzel; H Jost Achenbach; Ferdinand L G A Steinkrüger; Thomas Kalinski; Meinald Schultz; Jens Schreiber; Holger Amthauer; Christian Furth
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

6.  A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer.

Authors:  Yue Zhou; Song Gao; Yong Huang; Jinsong Zheng; Yinjun Dong; Baijiang Zhang; Shuqiang Zhao; Hong Lu; Zhibo Liu; Jinming Yu; Shuanghu Yuan
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

7.  Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.

Authors:  Guohua Shen; You Lan; Kan Zhang; Pengwei Ren; Zhiyun Jia
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

8.  Positron emission tomography/computed tomography findings of lung invasive adenocarcinoma subgroups and comparison of their short-term survivals.

Authors:  Bahar Ağaoğlu Şanlı; Fatma İlknur Ulugün; Volkan Karaçam; Duygu Gürel; Recep Bekiş; Aydın Şanlı; Nezih Özdemir
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

9.  Retention index of FDG-PET/CT SUVmax of the primary tumor in non-small cell lung cancer as a predictor of lymph node metastasis: a retrospective study.

Authors:  Toshinari Ema; Hideaki Kojima; Shinji Mizuno; Tatsuo Hirai; Mikako Oka; Hiroshi Neyatani; Kazuhito Funai; Norihiko Shiiya
Journal:  Eur J Hybrid Imaging       Date:  2022-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.